This document discusses the Rapaport-Leubering cycle, which is a supplementary pathway to glycolysis that operates in human and mammal red blood cells. The cycle is mainly concerned with synthesizing 2,3-bisphosphoglycerate from 1,3-bisphosphoglycerate produced in glycolysis using the enzyme 2,3-bisphosphoglycerate mutase. Approximately 15-25% of the glucose converted to lactate in red blood cells goes through this cycle of 2,3-bisphosphoglycerate synthesis.
4. This is supplementary pathway to glycolysis.
These operative in the erytrocyte of man and
other mammals.
Rapaport leubering cycle mainly concerned
with the synthesis of 2,3-bisphosphoglycerate
(2,3-BPG) in RBC.